PREVENT Risk Score Accurately IDs People With Coronary Artery Calcium
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 21, 2025 -- The 2023 Predicting Risk of Cardiovascular Disease Events (PREVENT) risk score accurately identifies individuals with coronary artery calcium (CAC), according to a research letter published online May 21 in the Journal of the American Heart Association.
Aaron J. Rhee, M.D., from New York University in New York City, and colleagues queried electronic health records to compare PREVENT risk scores with subclinical coronary atherosclerosis, detected through scoring of CAC deposits on coronary computed tomography angiography.
A total of 6,961 patients had no missing PREVENT inputs. The researchers found that PREVENT risk was <5, 5 to 7.5, 7.5 to 20, and >20 percent in 43.6, 15.8, 34.4, and 6.2 percent, respectively, with median CAC of 0, 0, 19, and 101, for each category. The Spearman correlation was 0.47 between PREVENT and CAC scores. Among those with PREVENT score <5 and 5 to 7.5 percent, 24.6 and 45.4 percent, respectively, had CAC ≥1. PREVENT scores provided good discrimination of CAC ≥1 and >100 (areas under the receiver operating characteristic curve, 0.755 and 0.761, respectively). Risk discrimination of incident myocardial infarction events was significantly improved by adding CAC to PREVENT risk (change in c-statistic, 0.014); the reverse was true but not statistically significant.
"The findings illustrate that PREVENT is accurate in identifying people who may have subclinical risk for cardiovascular disease, meaning blocked arteries before symptoms develop," coauthor Morgan E. Grams, M.D, Ph.D., also from New York University, said in a statement.
One author disclosed ties to Heartflow and Abbott Vascular.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-22 06:00
Read more

- FDA Approves Zevaskyn (prademagene zamikeracel) Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa
- One in 10 U.S. Internal Medicine Doctors Report High Degree of Burnout
- Top Science Journal Suspends Submissions Amid Budget Cuts
- Ubrogepant (Ubrelvy) Effective Against Early Migraine Symptoms
- Women With Autoimmune Disease At Greater Risk For Heart-Related Death
- Moderna's Combo Flu and COVID Shot Shows Promise
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions